BBS-Bioactive Bone Substitutes
0.053
EUR
-10.54 %
BONEH
First North Finland
Medical Equipment & Services
Health Care
3,947 following
-10.54%
-19.08%
-0.75%
-47.4%
-83.62%
-90.46%
-97.17%
-97.72%
-98.17%
BBS-Bioactive Bone Substitutes is a medical technology company. The company designs, develops and constructs biological implants for patients with bone defects and healing problems. The company's solutions are resold under the Artebone brand and are based on tricalcium phosphate (TCP) and bone protein, which stimulates the bone healing process. The company was founded in 2003 and is headquartered in Oulu.
Read moreMarket cap
1.47M EUR
Turnover
7.4K EUR
P/E (adj.) (24e)
-0.39
EV/EBIT (adj.) (24e)
-2.09
P/B (24e)
0.47
EV/S (24e)
694.29
Dividend yield-% (24e)
-
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
21.2
2025
Annual report '24
29.4
2025
General meeting '25
29.8
2025
Interim report Q2'25
Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
BBS-Bioactive Bone Substitutes Plc: Financial manager Annastiina Kauppinen resigns from the Company
BBS-Bioactive Bone Substitutes Plc: The Finnish Financial Supervisory Authority has imposed a penalty payment on a two current and one former member of Company’s Board of Directors
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Correction: BBS-Bioactive Bone Substitutes Oyj – Insider information: CEO Juliusz Rakowski has terminated the CEO agreement
BBS-Bioactive Bone Substitutes Oyj – Changes in the Management team: CEO Juliusz Rakowski has terminated the CEO agreement
BBS-Bioactive Bone Substitutes Plc: Financial calendar and Annual General Meeting in 2025
BBS-Bioactive Bone Substitutes Plc – Insider information: The results of change negotiations
